Vanda Pharmaceuticals Inc.
Organization details
- Legal name
- Vanda Pharmaceuticals Inc.
- Ownership
- Public
- Status
- Active
- Sector (GICS)
- Health Care
- SIC code
- 2834 — Pharmaceutical Preparations
- Jurisdiction of incorporation
- Delaware
- Headquarters city
- Washington
- Headquarters state / province
- District of Columbia
- Headquarters country
- United States
- Fiscal year end
- December
- Ticker symbol
- VNDA
- Primary stock exchange
- Nasdaq
Identifiers
- SEC CIK
- 0001347178
- EIN
- 03-0491827
Board of directors
-
Anne Sempowski Ward · DirectorSince 2023
-
Charles Cliff Duncan · DirectorSince 2026
-
Mihael Hristos Polymeropoulos · Director · President and CEOSince 2023
-
Phaedra Chrousos · DirectorSince 2023
-
Richard W. Dugan · DirectorSince 2023
-
Stephen Ray Mitchell · DirectorSince 2023
-
Tage Honore · DirectorSince 2023
Chief executives
Director election results
Annual meeting of June 4, 2026. Support is votes for as a share of votes for and against (or withheld). Below 80% is a clear protest.
-
85.9%
-
88.2%
-
93.1%
Board connections
1 of this board's directors also sit on 1 other board.
- via Anne Sempowski Ward
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
- Bought, last 12 months
- $38,094
- 3 purchases by 1 insider
- Sold, last 12 months
- $2,824,885
- 6 sales by 6 insiders
| Date | Insider | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Nov 5, 2026 | Charles Cliff Duncan Director | Open-market purchase | +5,803 | $3.80 | $22,076 |
| Nov 4, 2026 | Charles Cliff Duncan Director | Open-market purchase | +3,447 | $3.82 | $13,171 |
| Nov 3, 2026 | Charles Cliff Duncan Director | Open-market purchase | +750 | $3.80 | $2,847 |
| Jun 4, 2026 | McGuire Daniel Patrick Officer (SVP, GC and Secretary) | Grant or award | +80,000 | — | — |
| Jun 4, 2026 | Phaedra Chrousos Director | Grant or award | +41,600 | — | — |
| Jun 4, 2026 | Charles Cliff Duncan Director | Grant or award | +41,600 | — | — |
| Jun 4, 2026 | Richard W. Dugan Director | Grant or award | +41,600 | — | — |
| Jun 4, 2026 | Anne Sempowski Ward Director | Grant or award | +41,600 | — | — |
| Jun 4, 2026 | Tage Honore Director | Grant or award | +41,600 | — | — |
| Jun 4, 2026 | Stephen Ray Mitchell Director | Grant or award | +41,600 | — | — |
| May 18, 2026 | Stephen Ray Mitchell Director | Gift | −25,836 | — | — |
| Apr 22, 2026 | Charles Cliff Duncan Director | Grant or award | +57,101 | — | — |
| Mar 2, 2026 | Williams Timothy Officer (SVP & General Counsel) | Open-market sale | −42,434 | $8.27 | $350,929 |
| Mar 2, 2026 | Moran Kevin Patrick Officer (SVP, CFO & Treasurer) | Open-market sale | −42,442 | $8.27 | $350,995 |
| Mar 2, 2026 | Wijkstrom Joakim Officer (SVP, Chief Marketing Officer) | Open-market sale | −30,800 | $8.27 | $254,716 |
Peers
Compare boardsOrganizations in the same sector, closest in location and size first.
Questions about Vanda Pharmaceuticals Inc.
Who is the CEO of Vanda Pharmaceuticals Inc.?
Mihael Hristos Polymeropoulos is Vanda Pharmaceuticals Inc.'s President and CEO.
How many directors are on Vanda Pharmaceuticals Inc.'s board?
Vanda Pharmaceuticals Inc.'s board has 7 directors: Anne Sempowski Ward, Charles Cliff Duncan, Mihael Hristos Polymeropoulos, Phaedra Chrousos, Richard W. Dugan, Stephen Ray Mitchell and Tage Honore.
Are Vanda Pharmaceuticals Inc. insiders buying or selling shares?
Over the last 12 months, Vanda Pharmaceuticals Inc. insiders bought $38,094 of shares in 3 purchases and sold $2.8 million of shares in 6 sales on the open market, as reported to the SEC on Forms 4 and 5.
Embed this board on your site
Paste this where the board should appear. It always shows the current directors and links back here.
<div data-bod-board="vanda-pharmaceuticals-inc"></div>
<script src="https://boardofdirectors.review/embed.js" async></script>Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.